Since prominent gliosis was involved in AD pathogenesis as a result of neuroinflammatory response (Minter et al., 2016; Ransohoff, 2016), increases of TSPO and GFAP levels apparently exhibit reactive gliosis for a plaque formation. This evidence concerns the gene GFAP and Alzheimer disease.